Shopping Cart
- Remove All
Your shopping cart is currently empty
Edonentan (BMS 207940) hydrate effectively blocks the endothelin A (ETA) receptor as a potent and selective antagonist, featuring a K i of 10 pM. It exhibits complete (100%) oral bioavailability in rats [1].

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,820 | 10-14 weeks | |
| 50 mg | $2,380 | 10-14 weeks | |
| 100 mg | $3,100 | 10-14 weeks |
| Description | Edonentan (BMS 207940) hydrate effectively blocks the endothelin A (ETA) receptor as a potent and selective antagonist, featuring a K i of 10 pM. It exhibits complete (100%) oral bioavailability in rats [1]. |
| Targets&IC50 | ET A:10 pM (Ki) |
| In vivo | Edonentan (3-10 µmol/kg, orally) can block significant ET-1 pressor responses [1]. Compared to BMS-193884, Edonentan (BMS 207940) exhibits improved systemic clearance (Cl) and volume of distribution at steady state (Vss) [1]. |
| Synonyms | BMS 207940 hydrate |
| Molecular Weight | 554.66 |
| Formula | C28H34N4O6S |
| Cas No. | 264609-13-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.